pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4656 |
Genomic Coordinates | chr7: 4788565 - 4788639 |
Description | Homo sapiens miR-4656 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4656 | ||||||||||||||||||||||||||||||
Sequence | 10| UGGGCUGAGGGCAGGAGGCCUGU |32 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PHF19 | ||||||||||||||||||||
Synonyms | MTF2L1, PCL3, TDRD19B | ||||||||||||||||||||
Description | PHD finger protein 19 | ||||||||||||||||||||
Transcript | NM_015651 | ||||||||||||||||||||
Other Transcripts | NM_001009936 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PHF19 | |||||||||||||||||||||
3'UTR of PHF19 (miRNA target sites are highlighted) |
>PHF19|NM_015651|3'UTR 1 CTAGCCCCCGGGGGTGCCAGGGGTCCTGAAAACCAAAGGAGGAGCAGCAGAAGCCATAGGCTCCCCAGCTTTCTCCAGGC 81 TGGGGTGGGAGAAGGAAGCAGGACAGAGCTGCAAGTGCCTGGCAGAATGCCCTGCCTGCCTGCCTGCCAGGCCAAGGCCT 161 GCGTCTCTCTGCTGTACCAGCTCTGTTCCAGGGCCTCCTCAGGCTCGTTACCCCTGTGCCTGTGTCTCTACACACTCCAC 241 ACCCCCTCAAACTCTGTTTATCTGTTCTCTGACCTTGTGTCCCCTGCGCTGGGACCCTTCCTCCTGAGGCCCAGGTCTTT 321 GTCCCCAGTTGTGTGCCTTGACCTCTCTCGCCCCTTTCTGGGTGTGTTCGCACATCCTGTGTGTGCACAGCTGTCCCTCC 401 ACTGGATCCCCTTCACACGTGACCCGTGGGGCAGCCAGTCCTCCCAGGGACTACATAACAGGCACCTTTGAGAGAGCATG 481 GGAGAAGGTGGATAAGAGGATGCTGCTCAGTGCTTTTCTCTTCCACTTTCCTGCCACTCCCCACTACCCTCGGAGAGAGG 561 TGGTGGGATGGGAGAGAGCCCCTGTGAAAGCCTGTGAGGATCTGAAGAGTAAAGGGCTGGGTCTGCCTCAGAAGGCACCA 641 GCACCAGGGCCCAGGTATTAAGGCTGAGAGTGAAGGCTGCCAATGTCAGCTTTGGAGGTCCCAGAAGTCTTCTGTTCTCT 721 GGCCTCACCCCCTCAGTCGCCATAGAGCTGGGCCTGGCCTTGCTGGAATGGAGGCATCCTTCCAAACCTGGGGGACGGGG 801 GTGGGGGGTGGTAGTGGTGGGAGGGAAACCATGTCTTGCTAAACCTGTTTCTGGTGCCTCCCATCCCCAGACCCACCAGA 881 CACCACACAGCAGACAATACACACCCACTCGCACAAGCTTCCATCCACATGTGTTGTACTTTCAGCTCTAGGCATGCAGA 961 CAACCCCACACGGCCACACCACCACATGCCCAAGTGTACACACACAGAGCCACACCGTCCCTCTGGGCCTGCTGGCTCCT 1041 CCCTTGGCTTTCCCTTGGCCCACTTCCAGGGCCCAGGTGCTGCAACTAAATGTGAAAGCTCAGTGGCCGCTCCTTCTTTC 1121 AGCCCATCAACCAGCATTGGTCCCATAGGGAAGCACAGGGGACTCACCCTCTTTCATATCCCTTGCCCTGCCCTGAAATG 1201 GACAATCACTTTTTGGGATAGGTTGAAATTTTTAAAGAGCCTGCATCATTTGGTTCCCTCAAAGGGAAGCCCTTGCCAGT 1281 GGGGGTTTGAAAGAGAATTTTTGGAACCAACATTCAAATTCTGCCTCATCTGGAGGGAAACCAAAATTGGGAGGGGGAAG 1361 AGGACCCCTGATGTTTTGCTGCTTCCAGAGATATTAGAAACTGACTCACTTGATTGGAAAATGGACAAAAGTGCCTTGAC 1441 GTGGAGGGTGGGCACCAGATGGGGACCAGCCTTGCCAACTGCTGCTGTGGCCTCCAGCTTGGCTGGTTTTGCAGGCCGCC 1521 AGCAGGAAGGCGAAGGTGGTAGTACAGCAAGAGGCACTGGCGGGGCAGCAGGCCTGCAGGAGCTGTTTTTCCATTGCTAG 1601 GCCTGACCCCTCTCTACCTGTGAGCGTTCAGGGGGTCCCTGAGATAGTTTAGATGCCCCCCCATCTTAGACCTCAGCTCC 1681 CACAGTGCCTTTTAAGGGGGACCTCACCTCCTGTGCACAGCCCACCCACTTTCCTCTGCTTCCCTGGCACAGCCCAGGCA 1761 TAGACGAGCTGGCGTTGGACCCAGTTCTTCCCCCTTTTCAGCCCCACAGCTGCTGCCACAGGGGCCAACTAGGGCCAGGT 1841 GGAAGGGGAGCTGAGAAGCCAACCCCTAGCCCAGGGGTGCTGTGGGAACTGGGATCCAATTTGTAGCTTCCTGCCTGGCT 1921 TCAGAGAGCCCAGCAACCTTCTAGGCCTGCTTTCCAGACTTCTGAGATAGCCTGGGATGAGCAATCCTGTTATAGTACAT 2001 CTGGACCTTCCCTACCTGGGCTCTGGGGAGGCTGTGGGCCTGGAGAGGGAAAAGGAGGGAGGGGGTGTCTGCACCACCTG 2081 GGAAGATAGCACAAGGCCTAATGAGGTCACCCTGACTCCCCACCCCAGCATTTCATTCATACCAGATAATAGCTGCATTA 2161 CTGCCAACTGACCTTATAACCCTCTGCACCTTCAAAAAGATTCATGGTTTTTAATTGCTGCTTTTAATAACATTTGTTAA 2241 AGTTATAATTAATGTGTCTGATTTATGATTTAAAACCTCCCTTTGAACAATCAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000373896.3 | 3UTR | CCCACCCACUUUCCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
48 hsa-miR-4656 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT135536 | RAB5B | RAB5B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT168127 | SOX4 | SRY-box 4 | 2 | 2 | ||||||||
MIRT301229 | SH3BP4 | SH3 domain binding protein 4 | 2 | 2 | ||||||||
MIRT444362 | TIMM8B | translocase of inner mitochondrial membrane 8 homolog B | 2 | 2 | ||||||||
MIRT445909 | SLC10A3 | solute carrier family 10 member 3 | 2 | 2 | ||||||||
MIRT447283 | LAPTM5 | lysosomal protein transmembrane 5 | 2 | 2 | ||||||||
MIRT453797 | KBTBD12 | kelch repeat and BTB domain containing 12 | 2 | 2 | ||||||||
MIRT456777 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | 2 | 2 | ||||||||
MIRT459647 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | 2 | 2 | ||||||||
MIRT462333 | BCL7B | BCL tumor suppressor 7B | 2 | 2 | ||||||||
MIRT463535 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT465799 | TMEM91 | transmembrane protein 91 | 2 | 2 | ||||||||
MIRT470647 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT470837 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT471129 | PHF19 | PHD finger protein 19 | 2 | 2 | ||||||||
MIRT483310 | SLC35C2 | solute carrier family 35 member C2 | 2 | 2 | ||||||||
MIRT487264 | CCNF | cyclin F | 2 | 2 | ||||||||
MIRT491731 | SEMA3F | semaphorin 3F | 2 | 2 | ||||||||
MIRT497195 | DRP2 | dystrophin related protein 2 | 2 | 2 | ||||||||
MIRT508384 | SPTBN2 | spectrin beta, non-erythrocytic 2 | 2 | 4 | ||||||||
MIRT530496 | FADS6 | fatty acid desaturase 6 | 2 | 2 | ||||||||
MIRT546995 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 2 | 2 | ||||||||
MIRT549790 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT560368 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT566000 | RNF4 | ring finger protein 4 | 2 | 2 | ||||||||
MIRT574035 | PEX26 | peroxisomal biogenesis factor 26 | 2 | 2 | ||||||||
MIRT574231 | DMRT2 | doublesex and mab-3 related transcription factor 2 | 2 | 2 | ||||||||
MIRT576139 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT576640 | Mill2 | MHC I like leukocyte 2 | 1 | 1 | ||||||||
MIRT609875 | RAD54L2 | RAD54 like 2 | 2 | 4 | ||||||||
MIRT622651 | POU2F3 | POU class 2 homeobox 3 | 2 | 4 | ||||||||
MIRT628848 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT634252 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | 2 | 2 | ||||||||
MIRT634672 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT649087 | FBXO25 | F-box protein 25 | 2 | 2 | ||||||||
MIRT665019 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT666939 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT668960 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT675802 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT684022 | FOLR1 | folate receptor 1 | 2 | 2 | ||||||||
MIRT696480 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 2 | ||||||||
MIRT705894 | ADCY9 | adenylate cyclase 9 | 2 | 2 | ||||||||
MIRT709434 | ZSCAN25 | zinc finger and SCAN domain containing 25 | 2 | 2 | ||||||||
MIRT713572 | SLC2A8 | solute carrier family 2 member 8 | 2 | 2 | ||||||||
MIRT716697 | HLA-B | major histocompatibility complex, class I, B | 2 | 2 | ||||||||
MIRT719735 | SLC39A11 | solute carrier family 39 member 11 | 2 | 2 | ||||||||
MIRT724907 | DAO | D-amino acid oxidase | 2 | 2 | ||||||||
MIRT725321 | NFASC | neurofascin | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|